# Citations for Research Query

**Query:** # Disease Pathophysiology Research Template

## Target Disease
- **Disease Name:** Osteogenesis Imperfecta Type VII
- **MONDO ID:**  (if available)
- **Category:** Mendelian

## Research Objectives

Please provide a comprehensive research report on the pathophysiology of **Osteogenesis Imperfecta Type VII**.
Focus on the molecular and cellular mechanisms underlying disease progression.

### Required Information

#### 1. Core Pathophysiology
- What are the primary pathophysiological mechanisms?
- What molecular pathways are dysregulated?
- What cellular processes are affected?

#### 2. Key Molecular Players
- **Genes/Proteins**: Which genes are causally involved or implicated?
- **Chemical Entities**: What metabolites, drugs, or small molecules are relevant?
- **Cell Types**: Which cell types are primarily affected?
- **Anatomical Locations**: Which tissues/organs are involved?

#### 3. Biological Processes (for GO annotation)
- What biological processes (GO terms) are disrupted?
- Consider: signaling pathways, metabolic processes, cellular responses, transport, etc.

#### 4. Cellular Components
- Where in the cell do key processes occur?
- Consider: organelles, membrane compartments, extracellular space, etc.

#### 5. Disease Progression
- What is the sequence of events from initial trigger to clinical manifestation?
- Are there distinct stages or phases?

#### 6. Phenotypic Manifestations
- What are the key clinical phenotypes?
- How do they relate to the underlying mechanisms?

### Citation Requirements

- Cite primary literature (PMID preferred) for all mechanistic claims
- Prioritize recent reviews and landmark papers
- Include direct quotes where possible to support key statements

### Output Format

Structure your response as a narrative that could be used to populate a disease knowledge base entry with:
- Pathophysiology description
- Gene/protein annotations with ontology terms (HGNC, GO)
- Phenotype associations (HP terms)
- Cell type involvement (CL terms)
- Anatomical locations (UBERON terms)
- Chemical entities (CHEBI terms)
- Evidence items with PMIDs

**Provider:** falcon
**Generated:** 2026-02-04T19:43:40.924086

1. jovanovic2024updateonthe pages 8-9
2. marini2010nullmutationsin pages 4-5
3. dimori2020respiratorydefectsin pages 1-6
4. barnes2006deficiencyofcartilageassociated pages 1-2
5. zhou2024geneticanalysisphenotypic pages 1-1
6. valli2012deficiencyofcrtap pages 1-2
7. zhou2024geneticanalysisphenotypic pages 4-5
8. zhou2024geneticanalysisphenotypic pages 10-11
9. marini2010nullmutationsin pages 2-4
10. zhou2024geneticanalysisphenotypic pages 9-9
11. zhou2024geneticanalysisphenotypic pages 9-10
12. CRTAP
13. leads to
14. and
15. https://doi.org/10.1152/ajplung.00313.2019
16. https://doi.org/10.1056/NEJMoa063804
17. https://doi.org/10.1210/clinem/dgae025
18. https://doi.org/10.1007/s00223-024-01266-5
19. https://doi.org/10.1038/nm.3544;
20. https://doi.org/10.1152/ajplung.00313.2019;
21. https://doi.org/10.1038/nm.3544
22. https://doi.org/10.1007/s00441-009-0872-0;
23. https://doi.org/10.1111/j.1399-0004.2011.01794.x
24. https://doi.org/10.1007/s00441-009-0872-0
25. https://doi.org/10.1007/s00223-024-01266-5,
26. https://doi.org/10.1210/clinem/dgae025,
27. https://doi.org/10.1007/s00441-009-0872-0,
28. https://doi.org/10.1111/j.1399-0004.2011.01794.x,
29. https://doi.org/10.1056/nejmoa063804,
30. https://doi.org/10.1152/ajplung.00313.2019,